Abstract
Objectives
This study investigated the frequency of cancer-associated vasculitis, the types of associated cancers and vasculitides, and the temporal relationship in Korean patients who were diagnosed with both cancers and vasculitides.
Methods
This study performed a digital search of the clinical data repository using selected diagnostic terms of vasculitides among patients diagnosed with cancers from May 2001 to May 2021. The time gap between the time of diagnosis of ‘cancers’ and that of ‘vasculitides’ was limited to 3 years. The types of cancers and vasculitides were reviewed.
Results
The mean age of 73 patients with both cancers and vasculitides with a time gap of fewer than 3 years was 53.0 years and 42.5% were men. Of the 215,897 patients with cancers, 73 patients were also diagnosed with vasculitides (0.034%). The most common type of cancer was thyroid cancer (28.8%), followed by lymphoma (13.7%), whereas the most frequent type of vasculitis associated with cancer was Behcet disease (52.1%), followed by granulomatosis with polyangiitis (12.3%). The median time gap between cancer and vasculitis was − 17.0 days. Among vasculitides, Behcet disease was closely associated with various cancers compared to other types. Twenty-one patients exhibited both cancers and vasculitides between 0 and 90 days after the diagnosis of the corresponding cancer.
Conclusion
The frequency of cancer-associated vasculitis was 0.034% in Korean patients. The types of cancers and vasculitides in cancer-associated vasculitis and the distributions of sex and age may be dependent on ethnic and geographic differences.
Key Points • The frequency of cancer-associated vasculitis was 0.034% in Korean patients. • The most common cancer and vasculitis in cancer-associated vasculitis were thyroid cancer and Behcet disease. • The types of cancers and vasculitides in cancer-associated vasculitis seemed to be dependent on ethnic and geographic differences. |
Similar content being viewed by others
Abbreviations
- AAV:
-
ANCA-associated vasculitis
- ANCA:
-
Antineutrophil cytoplasmic antibody
- CHCC:
-
Chapel Hill Consensus Conference
- IRB:
-
Institutional review board
References
Jennette JC, Falk RJ, Andrassy K, Bacon PA, Churg J, Gross WL, Hagen EC, Hoffman GS, Hunder GG, Kallenberg CG et al (1994) Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 37(2):187–192. https://doi.org/10.1002/art.1780370206
Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F, Flores-Suarez LF, Gross WL, Guillevin L, Hagen EC, Hoffman GS, Jayne DR, Kallenberg CG, Lamprecht P, Langford CA, Luqmani RA, Mahr AD, Matteson EL, Merkel PA, Ozen S, Pusey CD, Rasmussen N, Rees AJ, Scott DG, Specks U, Stone JH, Takahashi K, Watts RA (2013) 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum 65(1):1–11. https://doi.org/10.1002/art.37715
Yuce Inel T, Gulcu A, Karakas A, Erdogan Yucel E, Onen F (2021) Coexistence of Takayasu arteritis and chronic myeloid leukemia: coincidental or paraneoplastic phenomenon? Int J Rheum Dis 24(9):1213–1216. https://doi.org/10.1111/1756-185X.14186
Chircop I, Boespflug A, Cini A, Lega JC, Dalle S (2021) Paraneoplastic polyarteritis nodosa in a patient with cutaneous T-cell lymphoma. Lancet Haematol 8(3):e240. https://doi.org/10.1016/S2352-3026(20)30393-8
Hutson TE, Hoffman GS (2000) Temporal concurrence of vasculitis and cancer: a report of 12 cases. Arthritis Care Res 13(6):417–423. https://doi.org/10.1002/1529-0131(200012)13:6%3c417::aid-art13%3e3.0.co;2-t
Wick MR, Patterson JW (2019) Cutaneous paraneoplastic syndromes. Semin Diagn Pathol 36(4):211–228. https://doi.org/10.1053/j.semdp.2019.01.001
Esperança-Martins M, Evangelista V, Fernandes S, Almeida R (2021) Vasculitis and breast cancer: mind the hint. Case Rep Oncol 14(1):550–560. https://doi.org/10.1159/000514729
Fain O, Hamidou M, Cacoub P, Godeau B, Wechsler B, Pariès J, Stirnemann J, Morin AS, Gatfosse M, Hanslik T, Belmatoug N, Blétry O, Cevallos R, Delevaux I, Fisher E, Hayem G, Kaplan G, Le Hello C, Mouthon L, Larroche C, Lemaire V, Piette AM, Piette JC, Ponge T, Puechal X, Rossert J, Sarrot-Reynauld F, Sicard D, Ziza JM, Kahn MF, Guillevin L (2007) Vasculitides associated with malignancies: analysis of sixty patients. Arthritis Rheum 57(8):1473–1480. https://doi.org/10.1002/art.23085
Solans-Laqué R, Bosch-Gil JA, Pérez-Bocanegra C, Selva-O’Callaghan A, Simeón-Aznar CP, Vilardell-Tarres M (2008) Paraneoplastic vasculitis in patients with solid tumors: report of 15 cases. J Rheumatol 35(2):294–304
Kaneko Y, Nunokawa T, Taniguchi Y, Yamaguchi Y, Gono T, Masui K, Kawakami A, Kawaguchi Y, Sato S, Kuwana M (2020) Clinical characteristics of cancer-associated myositis complicated by interstitial lung disease: a large-scale multicentre cohort study. Rheumatology (Oxford) 59(1):112–119. https://doi.org/10.1093/rheumatology/kez238
Criteria for diagnosis of Behçet’s disease (1990) International study group for Behçet’s disease. Lancet 335(8697):1078–1080
Arend WP, Michel BA, Bloch DA, Hunder GG, Calabrese LH, Edworthy SM, Fauci AS, Leavitt RY, Lie JT, Lightfoot RW Jr et al (1990) The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis. Arthritis Rheum 33(8):1129–1134. https://doi.org/10.1002/art.1780330811
Ozen S, Pistorio A, Iusan SM, Bakkaloglu A, Herlin T, Brik R, Buoncompagni A, Lazar C, Bilge I, Uziel Y, Rigante D, Cantarini L, Hilario MO, Silva CA, Alegria M, Norambuena X, Belot A, Berkun Y, Estrella AI, Olivieri AN, Alpigiani MG, Rumba I, Sztajnbok F, Tambic-Bukovac L, Breda L, Al-Mayouf S, Mihaylova D, Chasnyk V, Sengler C, Klein-Gitelman M, Djeddi D, Nuno L, Pruunsild C, Brunner J, Kondi A, Pagava K, Pederzoli S, Martini A, Ruperto N, Paediatric Rheumatology International Trials Organisation (PRINTO) (2010) EULAR/PRINTO/PRES criteria for Henoch-Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: Final classification criteria. Ann Rheum Dis 69(5):798–806. https://doi.org/10.1136/ard.2009.116657
Watts R, Lane S, Hanslik T, Hauser T, Hellmich B, Koldingsnes W, Mahr A, Segelmark M, Cohen-Tervaert JW, Scott D (2007) Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies. Ann Rheum Dis 66(2):222–227. https://doi.org/10.1136/ard.2006.054593
Masi AT, Hunder GG, Lie JT, Michel BA, Bloch DA, Arend WP, Calabrese LH, Edworthy SM, Fauci AS, Leavitt RY et al (1990) The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis). Arthritis Rheum 33(8):1094–1100. https://doi.org/10.1002/art.1780330806
Yazici Y, Hatemi G, Bodaghi B, Cheon JH, Suzuki N, Ambrose N, Yazici H (2021) Behçet syndrome. Nat Rev Dis Primers 7(1):67. https://doi.org/10.1038/s41572-021-00301-1
Rutter M, Bowley J, Lanyon PC, Grainge MJ, Pearce FA (2021) A systematic review and meta-analysis of the incidence rate of Takayasu arteritis. Rheumatology (Oxford) 60(11):4982–4990. https://doi.org/10.1093/rheumatology/keab406
Hong S, Won YJ, Park YR, Jung KW, Kong HJ, Lee ES, Community of Population-Based Regional Cancer Registries (2020) Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2017. Cancer Res Treat 52(2):335–350. https://doi.org/10.4143/crt.2020.206
Fayyaz B, Rehman HJ, Uqdah H (2019) Cancer-associated myositis: an elusive entity. J Community Hosp Intern Med Perspect 9(1):45–49. https://doi.org/10.1080/20009666.2019.1571880
Bang DS, Oh SH, Lee KH, Lee ES, Lee SN (2003) Influence of sex on patients with Behçet’s disease in Korea. J Korean Med Sci 18(2):231–235. https://doi.org/10.3346/jkms.2003.18.2.231
Jang SY, Seo SR, Park SW, Kim DK (2018) Prevalence of Takayasu’s arteritis in Korea. Clin Exp Rheumatol 36 Suppl 111(2):163–164
Choi CB, Park YB, Lee SW (2019) antineutrophil cytoplasmic antibody-associated vasculitis in Korea: a narrative review. Yonsei Med J 60(1):10–21. https://doi.org/10.3349/ymj.2019.60.1.10
Shim JO, Han K, Park S, Kim GH, Ko JS, Chung JY (2018) Ten-year nationwide population-based survey on the characteristics of children with Henoch-Schӧnlein Purpura in Korea. J Korean Med Sci 33(25):e174. https://doi.org/10.3346/jkms.2018.33.e174
Ishido T, Horita N, Takeuchi M, Kawagoe T, Shibuya E, Yamane T, Hayashi T, Meguro A, Ishido M, Minegishi K, Yoshimi R, Kirino Y, Kato S, Arimoto J, Ishigatsubo Y, Takeno M, Kurosawa M, Kaneko T, Mizuki N (2017) Clinical manifestations of Behçet’s disease depending on sex and age: results from Japanese nationwide registration. Rheumatology (Oxford) 56(11):1918–1927. https://doi.org/10.1093/rheumatology/kex285
Pyo JY, Ahn SS, Lee LE, Choe HN, Song JJ, Park YB, Lee SW (2021) Efficacy of the fibrosis index for predicting end-stage renal disease in patients with antineutrophil cytoplasmic antibody-associated vasculitis. Int J Clin Pract 75(4):e13929. https://doi.org/10.1111/ijcp.13929
Hetland LE, Susrud KS, Lindahl KH, Bygum A (2017) Henoch-Schönlein Purpura: a literature review. Acta Derm Venereol 97(10):1160–1166. https://doi.org/10.2340/00015555-2733
Funding
This work was supported by a grant from the Korea Health Technology R&D Project through the Korea Health Industry Development Institute, funded by the Ministry of Health and Welfare (HI14C1324), the Handok Inc., Seoul, Republic of Korea (HANDOK 2021–006), and CELLTRION PHARM, Inc. Chungcheongbuk-do, Republic of Korea (NCR 2019–6).
Author information
Authors and Affiliations
Contributions
H.D., J.Y.P., S.S.A. and S.W.L. developed and conceptualisation of the study. H.D., J.Y.P., S.S.A. and J.J.S. performed data curation and formal analyses. H.D., J.Y.P., S.S.A., Y.B.P. and S.W.L. completed methodology and project administration. Y.B.P. and S.W.L. supervised this study. H.D., J.Y.P. and S.W.L. participated in writing the draft manuscript, and all authors reviewed and edited the revised manuscript.
Corresponding author
Ethics declarations
Ethics approval
The present study was approved by the Institutional Review Board (IRB) of Severance Hospital (Seoul, Korea, IRB No. 4–2021-1707) and conducted according to the Declaration of Helsinki. Given the retrospective design of the study and the use of anonymised patient data, the requirement for written informed consent was waived.
Disclosures
None.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Supplementary Fig. 1.
Frequency of cancer-associated vasculitis within 1 year before and after the diagnosis of the corresponding cancer. (PNG 330 kb)
Supplementary Fig. 2.
Differences in the clinical features among cancer-associated vasculitides according to sex and age. (PNG 203 kb)
Rights and permissions
Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Do, H., Pyo, J.Y., Ahn, S.S. et al. Cancer-associated vasculitides: a single-centre case series. Clin Rheumatol 42, 151–158 (2023). https://doi.org/10.1007/s10067-022-06363-0
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-022-06363-0